North China Pharmaceutical Company.Ltd (SHA:600812)
China
· Delayed Price · Currency is CNY 6.09
+0.01 (0.16%)
May 21, 2025, 2:45 PM CST
SHA:600812 Revenue
North China Pharmaceutical Company.Ltd had revenue of 2.57B CNY in the quarter ending March 31, 2025, with 0.65% growth. This brings the company's revenue in the last twelve months to 9.89B, down -1.31% year-over-year. In the year 2024, North China Pharmaceutical Company.Ltd had annual revenue of 9.87B, down -2.48%.
Revenue (ttm)
9.89B
Revenue Growth
-1.31%
P/S Ratio
1.06
Revenue / Employee
980.01K
Employees
10,159
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | -250.63M | -2.48% |
| Dec 31, 2023 | 10.12B | -379.75M | -3.62% |
| Dec 31, 2022 | 10.50B | 115.37M | 1.11% |
| Dec 31, 2021 | 10.38B | -1.11B | -9.64% |
| Dec 31, 2020 | 11.49B | 35.02M | 0.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |